Opportunity Information: Apply for PAR 10 173

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "NIDA Research Education Program for Clinical Researchers and Clinicians (R25)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
  • This funding opportunity was created on Apr 20, 2010 and posted on Apr 20, 2010.
  • Applicants must submit their applications by Sep 7, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education City or township governments Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education County governments Native American tribal governments (Federally recognized) State governments Others (see text field entitled Additional Information on Eligibility for clarification) Public housing authorities/Indian housing authorities Small businesses Independent school districts.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
Apply for PAR 10 173

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The NIDA Research Education Program for Clinical Researchers and Clinicians (R25), Funding Opportunity Number PAR-10-173, is a discretionary NIH grant program from the National Institute on Drug Abuse designed to build and strengthen research education and research training for people pursuing clinically focused careers. The central aim is to develop the research skills, knowledge, and experience of participants who are on paths to become clinical researchers, practicing clinicians and service providers, or, ideally, professionals who can bridge both roles by combining research and clinical work. A key limitation is that this R25 mechanism is not intended to pay for purely clinical, non-research training; proposed activities must be explicitly research education and research training rather than general clinical instruction or service delivery preparation.

Applicant organizations are expected to propose structured research education experiences for specific career stages only. Under this opportunity, NIDA limits eligible participant levels to medical or graduate students, postdoctoral fellows, medical residents, and independent scientists. In other words, the program is meant to support research education spanning early professional development through more advanced, independent career phases, but it is not a catch-all training vehicle for every possible level or type of learner. The design should align clearly with one or more of those allowed stages and show how the curriculum, mentorship, and research exposure will move participants toward clinically oriented research careers.

In terms of content, the program is broadly open to research education and training activities in any topic area related to substance use, substance abuse, and addiction. NIDA highlights several areas as especially relevant: etiology (how substance use disorders develop and what drives risk and resilience), clinical assessment and diagnostics, treatment and intervention development, prevention research, health services research (including how care is delivered and improved in real-world settings), clinical neuroscience, medical consequences of drug abuse, and preclinical research when it is clearly connected to translational goals (for example, preclinical work that informs clinical approaches or accelerates movement from bench findings to patient care). The opportunity also encourages interdisciplinary approaches, including training that addresses comorbid conditions and downstream consequences of drug use, with HIV/AIDS named as a specific example. Programs that bring together multiple disciplines, perspectives, or methods to address complex substance-related health problems are consistent with the intent of the announcement.

Collaboration is another emphasized feature. NIDA encourages education partnerships and broader collaborations, which can include cross-departmental efforts within an institution, partnerships between institutions, or relationships with clinical sites and community-based settings when those partnerships meaningfully enhance research education. The overarching expectation is that the proposed environment and relationships will expand the quality, reach, and practical relevance of the research education experience, especially for clinically grounded participants.

The funding mechanism is the NIH Research Education (R25) grant. Awards under this mechanism support the design and implementation of research education programs rather than individual research projects, and they are institution-based in the sense that the education program is tied to the applicant organization. The announcement notes that research education programs funded through this mechanism generally may not be transferred from one institution to another unless there is a strong justification, signaling that the program is expected to be stable, institutionally anchored, and supported by the applicant organization’s training and research infrastructure.

Budget size, award duration, and the anticipated number of awards are not fixed in the summary information provided because NIDA expects applications to vary widely in scope and structure. As a result, both the amount of funding and the number of awards depend on the volume of applications received and, importantly, their quality, duration, and proposed costs. The opportunity does not require cost sharing or matching.

Eligibility is broad and includes many types of organizations, spanning public and private institutions of higher education, state and local governmental entities, tribal governments and tribal organizations, nonprofit organizations (including both 501(c)(3) and certain non-501(c)(3) nonprofits), for-profit organizations other than small businesses, small businesses, independent school districts, public housing authorities/Indian housing authorities, and a range of mission-focused institutions and communities such as HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, tribally controlled colleges and universities, faith-based or community-based organizations, eligible federal agencies, and U.S. territories or possessions. The program falls under CFDA 93.279 (Drug Abuse and Addiction Research Programs) and is categorized under Education/Health.

Administratively, the opportunity was posted on April 20, 2010, with an original and current closing date of September 7, 2012, and an archive date of October 8, 2012, indicating it is no longer active as a current competition under that specific posting. The full announcement and official details were made available through the NIH grants guide (PAR-10-173), and NIH provided a general contact route via the NIH Office of Extramural Research (OER) webmaster for access or linking issues.

Frequently Asked Questions (FAQs)

What is PAR-10-173 (NIDA Research Education Program for Clinical Researchers and Clinicians) meant to support?

PAR-10-173 is a discretionary NIH grant opportunity from the National Institute on Drug Abuse (NIDA) that supports institution-based research education and research training programs for people pursuing clinically focused careers. The emphasis is on building research skills, knowledge, and experience for participants who aim to become clinical researchers, practicing clinicians/service providers with strong research capacity, or professionals who combine clinical work and research.

What is the central goal of this R25 program?

The central goal is to develop participants into clinically oriented research professionals by providing structured research education experiences that strengthen their ability to conduct, understand, and apply research in substance use, substance abuse, and addiction-related areas.

Is this funding intended for purely clinical (non-research) training?

No. A key limitation of this R25 mechanism is that it is not intended to pay for purely clinical, non-research training. Proposed activities must be explicitly focused on research education and research training rather than general clinical instruction or preparation for service delivery alone.

What type of grant mechanism is used for this opportunity?

The funding mechanism is the NIH Research Education (R25) grant. It supports the design and implementation of research education programs rather than individual research projects, and it is tied to (anchored at) the applicant organization.

Who can participate in the research education program under this opportunity?

NIDA limits eligible participant levels to the following career stages: medical or graduate students, postdoctoral fellows, medical residents, and independent scientists. Programs are expected to propose structured experiences that align clearly with one or more of these allowed levels.

Are all learner levels eligible (for example, any clinical staff or any trainee type)?

No. The opportunity is not intended as a catch-all training vehicle for every possible level or type of learner. Applicants are expected to design the program specifically for the allowed participant levels: medical/graduate students, postdoctoral fellows, medical residents, and independent scientists.

What research topic areas are allowed under PAR-10-173?

The program is broadly open to research education and training activities in any topic area related to substance use, substance abuse, and addiction. NIDA highlights areas such as etiology, clinical assessment and diagnostics, treatment and intervention development, prevention research, health services research, clinical neuroscience, medical consequences of drug abuse, and preclinical research when clearly connected to translational goals.

Does NIDA allow preclinical research education components in an R25 program like this?

Yes, when preclinical research is clearly connected to translational goals, such as informing clinical approaches or accelerating movement from bench findings to patient care.

Are interdisciplinary and comorbidity-focused programs encouraged?

Yes. The opportunity encourages interdisciplinary approaches, including training that addresses comorbid conditions and downstream consequences of drug use. HIV/AIDS is specifically named as an example of a relevant comorbidity area.

Are collaborations or partnerships required or encouraged?

Collaboration is an emphasized feature. NIDA encourages education partnerships and broader collaborations, including cross-departmental efforts within an institution, partnerships between institutions, and relationships with clinical sites and community-based settings when those partnerships meaningfully enhance research education.

What is NIDA’s expectation for the training environment?

The proposed environment and relationships are expected to expand the quality, reach, and practical relevance of the research education experience, especially for clinically grounded participants.

Is this grant meant to fund individual research projects?

No. The R25 mechanism supports research education programs rather than individual research projects.

Can the funded research education program be transferred to another institution?

Generally, research education programs funded through this R25 mechanism may not be transferred from one institution to another unless there is a strong justification. This reflects an expectation that the program is stable and institutionally anchored.

Is cost sharing or matching required?

No. The opportunity does not require cost sharing or matching.

How much funding is available and how long are awards?

Budget size, award duration, and the anticipated number of awards are not fixed in the summary information provided. NIDA expects applications to vary widely in scope and structure, so funding levels and the number of awards depend on the volume of applications received and their quality, duration, and proposed costs.

What types of organizations are eligible to apply?

Eligibility is broad and includes (among others): public and private institutions of higher education; state and local government entities; tribal governments and tribal organizations; nonprofit organizations (including 501(c)(3) and certain non-501(c)(3) nonprofits); for-profit organizations other than small businesses; small businesses; independent school districts; public housing authorities/Indian housing authorities; eligible federal agencies; U.S. territories or possessions; and mission-focused institutions and communities such as HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, tribally controlled colleges and universities, and faith-based or community-based organizations.

What CFDA program is associated with this opportunity?

This opportunity falls under CFDA 93.279 (Drug Abuse and Addiction Research Programs) and is categorized under Education/Health.

Is this funding opportunity still open?

No. The opportunity was posted on April 20, 2010, with an original and current closing date of September 7, 2012, and an archive date of October 8, 2012. Based on those dates, it is no longer active as a current competition under that specific posting.

Where were the official details published?

The full announcement and official details were made available through the NIH grants guide under Funding Opportunity Number PAR-10-173.

Who is listed as a contact for access or linking issues?

NIH provided a general contact route via the NIH Office of Extramural Research (OER) webmaster for access or linking issues.

Browse more: Education Grants, Education Loans, Pell Grants

Browse more business programs for Education Programs

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: OVC FY10 Enforcing Victims Rights Direct Representation Through Legal Clinics

Previous opportunity: New Mexico Landscapes Restoration Stewardship Project

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 10 173

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 10 173) also looked into and applied for these:

Funding Opportunity
International Research Ethics Education and Curriculum Development Award (R25) Apply for PAR 10 174

Funding Number: PAR 10 174
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NIDA Mentored Clinical Scientists Development Program Award in Drug Abuse and Addiction (K12) Apply for PAR 10 177

Funding Number: PAR 10 177
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NIDA Research Center of Excellence Grant Program (P50) Apply for PAR 10 189

Funding Number: PAR 10 189
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NLM Independent Career Development Award for Biomedical Informatics (K22) Apply for PAR 10 195

Funding Number: PAR 10 195
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Centers of Biomedical Research Excellence (COBRE) Phase III Transitional Centers P30 Apply for PAR 10 196

Funding Number: PAR 10 196
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NLM Information Resource Grants to Reduce Health Disparities (G08) Apply for RFA LM 10 001

Funding Number: RFA LM 10 001
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
OVC FY 10 Mass Casualty and Violence at Home and Abroad Conference Apply for OVC 2010 2769

Funding Number: OVC 2010 2769
Agency: Office for Victims of Crime
Category: Education Health
Funding Amount: $655,000
NCRR Science Education Partnership Award (SEPA) (R25) Apply for PAR 10 206

Funding Number: PAR 10 206
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $250,000
Biology of Manual Therapies (R01) Apply for PA 10 209

Funding Number: PA 10 209
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Biology of Manual Therapies (R21) Apply for PA 10 210

Funding Number: PA 10 210
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
The Role of Microbial Metabolites in Cancer Prevention and Etiology (U01) Apply for PAR 10 208

Funding Number: PAR 10 208
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows In Nursing Research (F31) Apply for PAR 10 211

Funding Number: PAR 10 211
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Informed Decision Making in Young Adolescents at Risk for HIV/AIDS (R01) Apply for RFA NR 10 008

Funding Number: RFA NR 10 008
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $350,000
PHASE II IICOHRTA AIDS/TB Research Training Program (U2R) Apply for PAR 10 218

Funding Number: PAR 10 218
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
AIDS International Training and Research Program (AITRP) (D43) Apply for PAR 10 219

Funding Number: PAR 10 219
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NIDA Core Center of Excellence Grant Program (P30) Apply for PAR 10 220

Funding Number: PAR 10 220
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Pathobiology of Emerging Pathogens in Laboratory Animals (R21) Apply for RFA RR 10 004

Funding Number: RFA RR 10 004
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Pathobiology of Emerging Pathogens in Laboratory Animals (R01) Apply for RFA RR 10 005

Funding Number: RFA RR 10 005
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Clinical Proteomic Technologies for Cancer Initiative (CPTC) Proteome Characterization Centers (U24) Apply for RFA CA 10 016

Funding Number: RFA CA 10 016
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Pre application for a Biomedical Technology Research Center (X02) Apply for PAR 10 224

Funding Number: PAR 10 224
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 10 173", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.